End-of-day quote
Other stock markets
|
||
- GBX | - |
2016 | GlaxoSmithKline : Vectura to buy SkyePharma for 441 million pounds as UK biotech consolidates | RE |
2016 | Skyepharma : estimates full-year revenue ahead of its expectations | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 105,912,259 | 0 | 0 | - |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- Stock
- Company SkyePharma PLC